Can cosentyx have lasting side effects?

Can Cosentyx cause lasting side effects?

Some patients report joint pain, fatigue, or new autoimmune symptoms that continue after stopping Cosentyx. These effects appear in post-marketing reports and have not been quantified in large studies, so frequency remains unknown.

How common are persistent infections after Cosentyx?

Tuberculosis reactivation and serious fungal infections have been documented months after treatment ends. Guidelines recommend screening for latent TB before starting and monitoring for months afterward because reactivation can occur late.

What happens to the immune system long term?

Cosentyx blocks IL-17A, which normally protects against certain bacteria and fungi. Prolonged suppression may leave some patients more susceptible to recurrent infections or delayed wound healing even after drug clearance.

When does Cosentyx patent protection end?

The main U.S. patent for secukinumab expires in 2029, with possible extensions to 2031. Biosimilar competition could arrive shortly after, potentially affecting price and access.

Who makes Cosentyx and what alternatives exist?

Novartis manufactures Cosentyx. Clinicians often switch patients to other IL-17 inhibitors such as Taltz or Bimzelx, or to TNF inhibitors like Humira or Enbrel, depending on the condition being treated.

Do patients ask about cancer risk with Cosentyx?

Long-term registry data have not shown a clear increase in malignancy rates, yet some patients remain concerned because IL-17 pathways influence tumor surveillance. Ongoing studies continue to track this possibility.

Sources
[1] https://www.drugpatentwatch.com/drug/cosentyx